Our monthly report on AI, ML, DL, and NLP in healthcare looks at who, what, where, and how the use of artificial intelligence is changing healthcare for the better. We will bring you some of the latest news and product information along with thought leader posts and our AI playlist of episodes from Healthcare NOW Radio.
AI at Upcoming Events
ViVE – March 6-9 in Miami
AI’s Power Play: Leveraging the Advantage
The rise of machines in all industries has come with both promise and fear as we see AI taking over more and more tasks traditionally handled by humans. Promise is outplaying fear as AI has proven itself as a talented healthcare recruit to aid clinical decision making, research and backend operations, to name a few. What will this advanced technology really deliver in the next year – and will we leverage the advantage it provides us or miss this scoring opportunity?
HIMSS – March 14-18 in Orlando
Session Category: Data & Information – Artificial Intelligence and Machine Learning
HIMSS22 education sessions are led by world-renowned healthcare and innovation thought leaders and explore top-of-mind issues and challenges. Best of all, they are available for continuing education credits. If you are interested in learning more about AI in healthcare, 52 sessions are found in the category filter.
In the News
Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer’s Disease
Cognito Therapeutics (cognitotx), a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion (@aetioninc), a global real-world evidence (RWE) technology and analytics provider, announced a strategic partnership to develop a validated predictive model to identify patients with rapidly progressing mild cognitive impairment (MCI) and Alzheimer’s disease.
SkyPoint Cloud Announces Partnership with Leading Senior Care Company
SkyPoint Cloud (SkyPoint) (@skypointcloud), the privacy-first healthcare data and artificial intelligence (AI) platform that enables healthcare brands to build deeper relationships with their patients and residents, announced its partnership with Generations LLC (Generations), a company specializing in senior living community innovation, care, and vitality. Together, Generations and SkyPoint Cloud are revolutionizing how residents’ data can be used to empower caregivers and staff to make more informed care decisions. SkyPoint is the only healthcare data platform tailored for senior living communities.
Vapotherm Launches Strategic Partnership with Carnegie Mellon University to Deliver a Tailored Artificial Intelligence (AI) Program to Drive Better Outcomes for Patients Suffering from Chronic Respiratory Diseases
Vapotherm, Inc. (@Vapotherm), a global medical technology company focused on developing innovative, non-invasive technologies and digital health solutions for respiratory patients, announced a strategic partnership with Carnegie Mellon University, a world class AI research institution, to deliver a tailored artificial intelligence (AI) program for Vapotherm employees. The aim of the AI program, named Vapotherm AI for Business, is to tap into Carnegie Mellon’s AI expertise to provide a customized training program for Vapotherm employees that incorporates the use of AI to deliver better care, improve the quality of life, reduce the impact of chronic respiratory diseases, and lower healthcare costs for its customers.
Products
FDA Clears World’s First AI Software to Read Dental X-Rays
Pearl (@hello_pearl), a dental AI solutions company, announced that the United States Food and Drug Administration (FDA) has cleared its AI-powered, real-time pathology detection solution Second Opinion® to help dentists accurately identify a broad range of common dental conditions in patient x-rays.
Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools
Twist Bioscience Corporation (@TwistBioscience), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Eleven Therapeutics (@eleventx), a company leading the AI revolution in nucleic acid therapies, announced that they have created a replicon tool that could be used for studying viral genome replication and antiviral drug screening as well as vaccine and therapeutic development.
To Read
Bioengineering Solutions Bring Healthcare and Tech Together By Dan Matthews (@danielmatthews0) – Technology and medicine have always gone hand-in-hand, but the connections between bioengineering and healthcare have perhaps never been more important or apparent than now. Bioengineering solutions are not only revolutionizing the science of medicine, but they’re also innovating patient care.
AI-Enhanced Tools Help Personalize Rheumatoid Arthritis Treatment – By John Halamka MD & Paul Cerrato – One of the major problems that rheumatoid arthritis (RA) patients and their physicians must contend with before starting a drug regimen is deciding which of the many available agents to choose from. To date, it’s been a trial-and-error process, which means patients often endure months of continued pain and possible adverse reactions only to find they have been put on an ineffective medication. Part of the solution to this dilemma can be found in the field of pharmacogenomics.